GREN yields 20000000.00% · MRK yields 2.81%● Live data
📍 GREN pulled ahead of the other in Year 1
Combined, GREN + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GREN + MRK for your $10,000?
In June 2003, AgroCan Corporation changed its name to Greensmart Corporation in connection with an asset acquisition agreement with Winsmart Development, Ltd. According to the basic terms of the agreement, the company would issue to Winsmart 29,868,737 shares of its common stock. Also, Winsmart would sell to the company approximately 553,212 young eucalyptus trees planted in a total of 340 leased hectares; and a tree seedling and nursery farm situated on 3.3 leased hectares. Greensmart Corporation, through its subsidiary, AgroCan (China), Inc., specializes in producing compound fertilizers, which are custom-made to suit local conditions, such as plant, soil, and climate. Compound fertilizers are the end product made from the combination of the three primary nutrients: nitrogen, phosphate, and potassium, together with other elements, such as iron, zinc, copper, and manganese. These elements are blended in different proportions, and are made into pellets and packed into bags. Fertilizer applications include mainly paddy rice, wheat, corn, sugar cane, tobacco, cotton, vegetables, tree plantation, and fruit trees. The company's fertilizers are sold under the brand name 'AgroCan Three Leaves'. Its main customers for the fertilizers comprise the farming supply bureaus and cooperatives under the State Internal Trade Bureau of the People's Republic of China. These entities act as wholesalers to individual farmers. State-owned farms and plantations are also major accounts of the company. Greensmart Corporation was founded in 1996 and is based in Kwun Tong, Hong Kong.
Full GREN Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.